Skip to main content

Full text of "USPTO Patents Application 09578669"

See other formats


o 



^ 5 - &o 




UTILITY PATENT APPLICATION TRANSMITTAL (Large Entity) 

Only for new nonprovisional applications under 37 C.F.R. 1.53(b) 



Docket No. 
2831 -E 



Express Mail Label No.: 
EL333159549US 



TO THE ASSISTANT COMMISSIONER FOR PATENTS 
BOX PATENT APPLICATION 
Washington, D.C. 20231 

Transmitted herewith for filing under 35 U.S.C. 1 1 1 (a) and 37 C.F.R. 1 .53(b) is a new utility patent g*=* 
application for an invention entitled: ^ 



ANTAGONISTS OF INTERLEUKIN-15 



and invented by: 



Kenneth H. Grabstein, residing at Mercer Island, Washington, Dean K. Pettit, residing at 
Seattle, Washington, and Raymond J. Paxton, residing at Bellevue, Washington. 



If a CONTINUING APPLICATION, check appropriate box and supply the requisite information: 
EI Continuation □ Divisional □ Continuation-in-part (CIP) 

of prior application No.: 09/196,427 

Enclosed are: 

Application Elements 

1 . El Filing fee as calculated and transmitted as described below 

2. [El Specification including claims and abstract ( 28 pages total) 

3. □ Drawing(s); Number of Sheets 

4. lEl Oath or Declaration 

a. □ Newly executed 

b. El Copy from a prior application (37.C.F.R. 1 .63(d)) (for continuation/divisional 

application only) 

c. [EI With Power of Attorney □ Without Power of Attorney 

d. □ DELETION OF INVENTOR(S) 

Signed statement attached deleting inventor(s) named in prior application, see 37 
C.F.R. 1.63(d)(2) and 1.33(b). 

5. El Incorporation by Reference (usable if Box 4b is checked) 

The entire disclosure of the prior application from which a copy of the oath or 
declaration is supplied under Box 4b, is considered as being part of the disclosure of 
the accompanying application and is hereby incorporated by reference therein. 

6. □ Computer Program in Microfiche (Appendix) 

7. [El Nucleotide and/or Amino Acid Sequence Submission 

a. El Paper copy 

Pages 21 - 25 of specification 



□ Separately numbered pages . 



b. □ Computer Readable Copy 

c. EI Statement Verifying Identical Paper and Computer Readable Copy 

d. El Statement under 37 C.F.R. 1 .821 (e) in lieu of Computer Readable Copy 



• 



UTILITY PATENT APPLICATION TRANSMITTAL (Large Entity) 



D cket No.: 2831 -E 



Accompanying Application Parts 

8. □ Assignment 

a. □ Executed original Assignment and Recordation Form enclosed 

b. □ Prior application is assigned of record to Immunex Corporation 

(reel frame ) 

9. □ 37 C.F.R. 3.73(B) Statement (when there is an assignee) 

10. (El Preliminary Amendment 

11. (El Acknowledgment postcard 

1 2. m Certificate of Mailing by Express Mail (Label No.: EL3331 59549US) 

1 3. □ Certified Copy of Priority Document(s) (if foreign priority is claimed) 

14. □ Additional Enclosures (please identify beloW): 



Fee Calculation and Transmittal 



CLAIMS AS FILED (after any Preliminary Amendment submitted herewith) 


For 


# Filed 


# Allowed 


# Extra 


Rate 


Fee 


Total Claims 


6 


- 20 = 


0 


x $18.00 


$0.00 


Indep. Claims 


1 


- 3 = 


0 


x $78.00 


$0.00 


Multiple Dependent Claims (check if applicable) □ 


$0.00 


BASIC FEE 


$690.00 


OTHER FEE (specify purpose) 


$0.00 


TOTAL FILING FEE 


$690.00 



M The Commissioner is hereby authorized to charge and credit Deposit Account No. 09-0089 as 
described below. A copy of this sheet is enclosed. 



\E\ Charge the amount of $690 as a filing fee. 
IEI Credit any overpayment. 

[El Charge any additional fees required under 37 C.F.R. 1.16 and 1.17. 



Correspondence address: Julie K. Smith, Ph.D 

Registration No. 38,61 
Immunex Corporation 
Law Department 

51 University Street Dated: May 25, 2000 

Seattle, Washington 98101 

lelephone: (206) 587^0430 




be251001 5/25/00 



2 



IN THE UNITED STATES PATENT AND TRADEMARK OFFICE 



In the Application of: 



Docket No.: 283 1-E 



Kenneth H. Grabstein, Dean K. Petti t, 
and Raymond J. Paxton 



Serial No.: 



—to be assigned— 



Art Unit: 



unknown 



Filed: 



May 25, 2000 



Examiner: 



unknown 



For: 



ANTAGONISTS OF INTERLEUKIN- 1 5 



CERTIFICATE OF MAILING BY EXPRESS MAIL 



BOX PATENT APPLICATION 
Assistant Commissioner for Patents 
Washington, D.C. 20231 



EXPRESS MAIL LABEL NUMBER: EL333159549US 



I hereby certify that the enclosed correspondence is being deposited with the United 
States Postal Service "Express Mail Post Office to Addressee" service under 37 CFR §1.10 
on the date listed below, and is addressed to BOX PATENT APPLICATION, Assistant 
Commissioner for Patents, Washington, D.C. 20231. 

Patent Application Transmittal Letter (2 pages + copy) 

Preliminary Amendment (2 pages), including replacement paper copy 

of Sequence Listing (pages 21-25) 
Specification, Claims and Abstract (28 pages) 
Statement Under 37 CFR § 1.821 (e) and (f) 
Copy of Originally filed Declaration and Power of Attorney 
Postcard 



Signd 



^- Nanci M.^Certsdn 



Dat<